Logo image of CHR-DB-B.CA

CHORUS AVIATION INC (CHR-DB-B.CA) Stock Fundamental Analysis

TSX:CHR-DB-B - Toronto Stock Exchange - CA17040TAE25 - Currency: CAD

102  +1.5 (+1.49%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CHR-DB-B. CHR-DB-B was compared to 9 industry peers in the Passenger Airlines industry. CHR-DB-B has only an average score on both its financial health and profitability. CHR-DB-B is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year CHR-DB-B was profitable.
CHR-DB-B had a positive operating cash flow in the past year.
In multiple years CHR-DB-B reported negative net income over the last 5 years.
CHR-DB-B had a positive operating cash flow in each of the past 5 years.
CHR-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

The Return On Assets of CHR-DB-B (-17.42%) is worse than 77.78% of its industry peers.
With a Return On Equity value of -47.80%, CHR-DB-B is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
CHR-DB-B has a Return On Invested Capital of 6.29%. This is in the better half of the industry: CHR-DB-B outperforms 77.78% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CHR-DB-B is in line with the industry average of 5.50%.
The last Return On Invested Capital (6.29%) for CHR-DB-B is above the 3 year average (5.30%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -17.42%
ROE -47.8%
ROIC 6.29%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
CHR-DB-B.CA Yearly ROA, ROE, ROICCHR-DB-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

CHR-DB-B has a Operating Margin (6.77%) which is comparable to the rest of the industry.
CHR-DB-B's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 65.04%, CHR-DB-B is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
In the last couple of years the Gross Margin of CHR-DB-B has declined.
Industry RankSector Rank
OM 6.77%
PM (TTM) N/A
GM 65.04%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
CHR-DB-B.CA Yearly Profit, Operating, Gross MarginsCHR-DB-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHR-DB-B is destroying value.
CHR-DB-B has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CHR-DB-B has been increased compared to 5 years ago.
CHR-DB-B has a better debt/assets ratio than last year.
CHR-DB-B.CA Yearly Shares OutstandingCHR-DB-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHR-DB-B.CA Yearly Total Debt VS Total AssetsCHR-DB-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CHR-DB-B has an Altman-Z score of 2.24. This is not the best score and indicates that CHR-DB-B is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.24, CHR-DB-B belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
CHR-DB-B has a debt to FCF ratio of 3.86. This is a good value and a sign of high solvency as CHR-DB-B would need 3.86 years to pay back of all of its debts.
CHR-DB-B has a Debt to FCF ratio of 3.86. This is in the better half of the industry: CHR-DB-B outperforms 77.78% of its industry peers.
A Debt/Equity ratio of 0.68 indicates that CHR-DB-B is somewhat dependend on debt financing.
CHR-DB-B has a Debt to Equity ratio of 0.68. This is in the better half of the industry: CHR-DB-B outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 3.86
Altman-Z 2.24
ROIC/WACC0.72
WACC8.76%
CHR-DB-B.CA Yearly LT Debt VS Equity VS FCFCHR-DB-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.22 indicates that CHR-DB-B should not have too much problems paying its short term obligations.
CHR-DB-B has a Current ratio (1.22) which is comparable to the rest of the industry.
CHR-DB-B has a Quick Ratio of 1.22. This is a bad value and indicates that CHR-DB-B is not financially healthy enough and could expect problems in meeting its short term obligations.
CHR-DB-B has a Quick ratio of 0.71. This is in the lower half of the industry: CHR-DB-B underperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.71
CHR-DB-B.CA Yearly Current Assets VS Current LiabilitesCHR-DB-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

CHR-DB-B shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.14%.
CHR-DB-B shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -19.03% yearly.
Looking at the last year, CHR-DB-B shows a very negative growth in Revenue. The Revenue has decreased by -14.15% in the last year.
The Revenue has been growing slightly by 0.56% on average over the past years.
EPS 1Y (TTM)-5.14%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%35.71%
Revenue 1Y (TTM)-14.15%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-18.31%

3.2 Future

CHR-DB-B is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.82% yearly.
Based on estimates for the next years, CHR-DB-B will show a small growth in Revenue. The Revenue will grow by 0.78% on average per year.
EPS Next Y62.27%
EPS Next 2Y16.29%
EPS Next 3Y8.82%
EPS Next 5YN/A
Revenue Next Year-2.29%
Revenue Next 2Y-2.03%
Revenue Next 3Y0.78%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CHR-DB-B.CA Yearly Revenue VS EstimatesCHR-DB-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CHR-DB-B.CA Yearly EPS VS EstimatesCHR-DB-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 61.45, the valuation of CHR-DB-B can be described as expensive.
CHR-DB-B's Price/Earnings ratio is in line with the industry average.
CHR-DB-B is valuated expensively when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 49.95 indicates a quite expensive valuation of CHR-DB-B.
The rest of the industry has a similar Price/Forward Earnings ratio as CHR-DB-B.
When comparing the Price/Forward Earnings ratio of CHR-DB-B to the average of the S&P500 Index (35.33), we can say CHR-DB-B is valued slightly more expensively.
Industry RankSector Rank
PE 61.45
Fwd PE 49.95
CHR-DB-B.CA Price Earnings VS Forward Price EarningsCHR-DB-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHR-DB-B is valued a bit more expensive than the industry average as 77.78% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHR-DB-B is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 24.87
EV/EBITDA 16.36
CHR-DB-B.CA Per share dataCHR-DB-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.99
PEG (5Y)N/A
EPS Next 2Y16.29%
EPS Next 3Y8.82%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CHR-DB-B!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHORUS AVIATION INC

TSX:CHR-DB-B (7/14/2025, 7:00:00 PM)

102

+1.5 (+1.49%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners2.5%
Inst Owner ChangeN/A
Ins Owners1.32%
Ins Owner ChangeN/A
Market Cap2.70B
Analysts78.18
Price Target133.9 (31.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-7.29%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.69%
Min EPS beat(2)3.87%
Max EPS beat(2)25.51%
EPS beat(4)3
Avg EPS beat(4)39.29%
Min EPS beat(4)-80.2%
Max EPS beat(4)207.96%
EPS beat(8)4
Avg EPS beat(8)7.83%
EPS beat(12)5
Avg EPS beat(12)1.78%
EPS beat(16)7
Avg EPS beat(16)0.15%
Revenue beat(2)0
Avg Revenue beat(2)-3.86%
Min Revenue beat(2)-3.95%
Max Revenue beat(2)-3.78%
Revenue beat(4)0
Avg Revenue beat(4)-6.49%
Min Revenue beat(4)-10.27%
Max Revenue beat(4)-3.78%
Revenue beat(8)3
Avg Revenue beat(8)-1.85%
Revenue beat(12)5
Avg Revenue beat(12)-1.08%
Revenue beat(16)9
Avg Revenue beat(16)6.44%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.14%
EPS NY rev (1m)0%
EPS NY rev (3m)8.79%
Revenue NQ rev (1m)-0.29%
Revenue NQ rev (3m)-0.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 61.45
Fwd PE 49.95
P/S 1.94
P/FCF 24.87
P/OCF 18.06
P/B 5.23
P/tB 5.32
EV/EBITDA 16.36
EPS(TTM)1.66
EY1.63%
EPS(NY)2.04
Fwd EY2%
FCF(TTM)4.1
FCFY4.02%
OCF(TTM)5.65
OCFY5.54%
SpS52.7
BVpS19.51
TBVpS19.18
PEG (NY)0.99
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.42%
ROE -47.8%
ROCE 8.48%
ROIC 6.29%
ROICexc 6.74%
ROICexgc 6.8%
OM 6.77%
PM (TTM) N/A
GM 65.04%
FCFM 7.78%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexcg growth 3Y33.52%
ROICexcg growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 3.86
Debt/EBITDA 1.9
Cap/Depr 45.9%
Cap/Sales 2.93%
Interest Coverage 1.46
Cash Conversion 81.41%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.71
Altman-Z 2.24
F-Score6
WACC8.76%
ROIC/WACC0.72
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.14%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%35.71%
EPS Next Y62.27%
EPS Next 2Y16.29%
EPS Next 3Y8.82%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.15%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-18.31%
Revenue Next Year-2.29%
Revenue Next 2Y-2.03%
Revenue Next 3Y0.78%
Revenue Next 5YN/A
EBIT growth 1Y-59.15%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year88.24%
EBIT Next 3Y15.21%
EBIT Next 5YN/A
FCF growth 1Y-55.84%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-51.04%
OCF growth 3Y12.73%
OCF growth 5Y0.25%